Journal of Comparative Effectiveness Research

Papers
(The H4-Index of Journal of Comparative Effectiveness Research is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-01-01 to 2025-01-01.)
ArticleCitations
Healthcare resource utilization and costs among patients with alpha-1 antitrypsin deficiency with liver and/or lung disease: a longitudinal retrospective study in the USA77
Novel and existing flexible survival methods for network meta-analyses66
Effect of home-based exercise programs with e-devices on falls among community-dwelling older adults: a meta-analysis39
The economic cost of racial disparities in patients undergoing cardiac valve repair or replacement33
Uricemia in the acute phase of myocardial infarction and its relation to long-term mortality risk32
Heterogeneity in renal end points of cardiovascular outcomes trials in Type 2 diabetes30
Does off-hours endoscopic hemostasis affect outcomes of nonvariceal upper gastrointestinal bleeding?22
Letter in reply20
Corrigendum20
The views of teenagers with obesity, their caregivers, and doctors: a plain language summary of the ACTION Teens global survey19
Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost–effectiveness analysis19
Impact of pain and nonpain co-morbidities on opioid use in women with endometriosis17
Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam in the long-term care setting in the USA17
Impact analysis of expanding anti-TNF therapy for Crohn’s disease16
Design and methods of a tailored approach for diabetes prevention in women with previous gestational diabetes16
Journal of Comparative Effectiveness Research : 2022 year in review15
0.039835214614868